Mirae Asset Global Investments’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Buy |
|
|||||
|
2025
Q1 | $95.3K | Buy |
|
|||||
|
2024
Q4 | $94K | Sell |
|
|||||
|
2024
Q3 | $94.1K | Buy |
|
|||||
|
2024
Q2 | $80.8K | Sell |
|
|||||
|
2024
Q1 | $1.42M | Sell |
|
|||||
|
2023
Q4 | $2.69M | Buy |
|
|||||
|
2023
Q3 | $1.7M | Buy |
|
|||||
|
2023
Q2 | $1.79M | Sell |
|
|||||
|
2023
Q1 | $1.44M | Buy |
|
|||||
|
2022
Q4 | $967K | Buy |
|
|||||
|
2022
Q3 | $980K | Buy |
|
|||||
|
2022
Q2 | $646K | Buy |
|
|||||
|
2022
Q1 | $289K | Sell |
|
|||||
|
2021
Q4 | $290K | Buy |
|
|||||
|
2021
Q3 | $204K | Buy |
|
|||||
|
2021
Q2 | $258K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $450K | Buy |
|
|||||
|
2020
Q3 | $333K | Buy |
|
|||||
|
2020
Q2 | $352K | Buy |
|